NDC Package 70436-113-82 Cisatracurium Besylate

Injection Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70436-113-82
Package Description:
10 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE
Product Code:
Proprietary Name:
Cisatracurium Besylate
Non-Proprietary Name:
Cisatracurium Besylate
Substance Name:
Cisatracurium Besylate
Usage Information:
Cisatracurium Besylate Injection is indicated:as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients 1 month to 12 years of ageto provide skeletal muscle relaxation in adults during surgical procedures or during mechanical ventilation in the ICUto provide skeletal muscle relaxation during surgical procedures via infusion in pediatric patients 2 years and olderLimitations of UseCisatracurium Besylate Injection is not recommended for rapid sequence endotracheal intubation due to the time required for its onset of action.
11-Digit NDC Billing Format:
70436011382
NDC to RxNorm Crosswalk:
  • RxCUI: 199211 - cisatracurium 2 MG/ML Injectable Solution
  • RxCUI: 199211 - cisatracurium (as cisatracurium besylate) 2 MG/ML Injectable Solution
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Slate Run Pharmaceuticals, Llc
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA216538
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    12-01-2023
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 70436-113-82?

    The NDC Packaged Code 70436-113-82 is assigned to a package of 10 vial, single-dose in 1 carton / 10 ml in 1 vial, single-dose of Cisatracurium Besylate, a human prescription drug labeled by Slate Run Pharmaceuticals, Llc. The product's dosage form is injection and is administered via intravenous form.

    Is NDC 70436-113 included in the NDC Directory?

    Yes, Cisatracurium Besylate with product code 70436-113 is active and included in the NDC Directory. The product was first marketed by Slate Run Pharmaceuticals, Llc on December 01, 2023 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 70436-113-82?

    The 11-digit format is 70436011382. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-270436-113-825-4-270436-0113-82